Boston Scientific has announced the commencement of clinical investigation evaluating the use of the WallFlex Biliary RX Stent as a bridge to surgery among certain cancer patients. Read More
St Jude Medical has been granted European CE Mark approval for a new disease assessment tool designed to aid physicians treating patients with coronary artery disease. Read More
Pfizer has named the Newcastle upon Tyne Hospitals NHS Foundation Trust as the first UK partner under its Inspire clinical research programme. Read More
Novartis has won an award for its Arogya Parivar social ventures initiative from GBCHealth, a coalition of more than 230 private sector companies working to improve global health. Read More
Sanofi has announced the commencement of a pair of phase III trials for sarilumab, a rheumatoid arthritis therapy that represents the first fully human monoclonal antibody directed against the IL-6 re... Read More
Amgen has announced results from analyses of its metastatic colorectal cancer therapy Vectibix that identify new predictive biomarkers that could inform treatment strategies in future. Read More
BCF Technology has received positive testimony for the GE Logiq S7 Expert ultrasound scanner from Vets Now Referrals, a client based in Glasgow. Read More
Bayer HealthCare has agreed a deal to acquire Steigerwald Arzneimittelwerk, a privately-held pharmaceutical company specialising in the creation of pharmacy-only herbal medicines. Read More
Scientists have highlighted the potential of active motion-based videogames as a means of improving children's health and lowering the risk posed by obesity. Read More
PerkinElmer has announced that its OneSource Strategic Lab Solutions brand is to be expanded to incorporate strategic laboratory consulting services. Read More
Steris has announced the launch of the VaproQuip Decontamination Room, a modular system that can transform equipment storage room areas into high-turn processing centres. Read More
Bristol-Myers Squibb has announced that new data on its approved and investigational immuno-oncology compounds will be presented at the upcoming annual meeting of the American Society of Clinical Onco... Read More
AstraZeneca has announced that it will be moving three of its most promising cancer compounds forward to phase III clinical development over the coming months. Read More
